Related Experiment Video
Updated: Mar 7, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant
Yueqiu Teng1, Yu-Cui Dong1, Zhaoyu Liu1
1Department of Immunology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.
Abstract:
The methylation-mediated silencing of tumor suppressors, including key apoptosis-related genes plays an important role in the pathogenesis and therapeutic resistance in human cancer. In this study, we aimed to elucidate the role and mechanisms of resistance to apoptosis with caspase-8 gene downregulation in human malignant glioma. Reverse transcription-polymerase chain reaction (RT-PCR) and methylation-specific PCR (MSP) were used to examine caspase-8 expressoin at the mRNA level and gene methylation status in normal brain tissue, glioma tissue and cancer cell lines. Caspase-8 protein kinase activity was measured by caspase-8 colorimetric assays; cell apoptosis was examined by Annexin V/propidium iodide (PI) staining; the rates of tumor cell apoptosis were detected by flow cytometry. Our results revealed that caspase-8 gene silencing may result from the methylation of its gene promoter in human glioma tissues. The expression of caspase-8 at the mRNA level was significantly associated with the grade of human glioma. In certain human cancer cell lines, the expression at the mRNA level, protein kinase activity and tumor cell anti-apoptotic activity and resistance were related to the methylation status of the caspase-8 gene promoter. Thus, the caspase-8 gene methylation status may be used as an indicator for the early diagnosis of human malignant glioma. Combination therapy with demethylation reagents may overcome therapeutic resistance in the same malignancy.
Insights
Methylation silences the caspase-8 gene in human malignant glioma, promoting cancer growth and therapeutic resistance. Targeting this gene methylation could aid early diagnosis and overcome treatment resistance.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Methylation-mediated silencing of tumor suppressors, including apoptosis-related genes, is crucial in cancer pathogenesis and therapeutic resistance.
- Understanding resistance to apoptosis via caspase-8 gene downregulation is vital in human malignant glioma.
Purpose of the Study:
- To elucidate the role and mechanisms of apoptosis resistance linked to caspase-8 gene downregulation in human malignant glioma.
- To investigate the association between caspase-8 gene methylation and glioma progression.
Main Methods:
- Reverse transcription-polymerase chain reaction (RT-PCR) and methylation-specific PCR (MSP) to assess caspase-8 mRNA expression and gene methylation status.
- Caspase-8 colorimetric assays for protein kinase activity.
- Annexin V/propidium iodide (PI) staining and flow cytometry to evaluate cell apoptosis.
Main Results:
- Caspase-8 gene silencing in human glioma tissues is likely due to promoter methylation.
- Caspase-8 mRNA expression significantly correlates with glioma grade.
- In cancer cell lines, caspase-8 expression, activity, and apoptosis resistance are linked to promoter methylation status.
Conclusions:
- Caspase-8 gene methylation status may serve as an early diagnostic indicator for human malignant glioma.
- Combination therapy with demethylation reagents holds potential to overcome therapeutic resistance in glioma.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Apoptosis

